Cited by 586Renin-Angiotensin System StudiesAtherosclerosis and Cardiovascular DiseasesNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Vascular Inflammation and the Renin-Angiotensin System

Brasier, Allan R., Recinos, Adrian, Eledrisi, Mohsen S.·2002·Arteriosclerosis, Thrombosis, and Vascular Biology

DOI 10.1161/01.atv.0000021412.56621.a2

Open this paper in CoChat — free account

Abstract

It is now well established that vascular inflammation is an independent risk factor for the development of atherosclerosis. In otherwise healthy patients, chronic elevations of circulating interleukin-6 or its biomarkers are predictors for increased risk in the development and progression of ischemic heart disease. Although multifactorial in etiology, vascular inflammation produces atherosclerosis by the continuous recruitment of circulating monocytes into the vessel wall and by contributing to an oxidant-rich inflammatory milieu that induces phenotypic changes in resident (noninflammatory) cells. In addition, the renin-angiotensin system (RAS) has important modulatory activities in the atherogenic process. Recent work has shown that angiotensin II (Ang II) has significant proinflammatory actions in the vascular wall, inducing the production of reactive oxygen species, inflammatory cytokines, and adhesion molecules. These latter effects on gene expression are mediated, at least in part, through the cytoplasmic nuclear factor-kappaB transcription factor. Through these actions, Ang II augments vascular inflammation, induces endothelial dysfunction, and, in so doing, enhances the atherogenic process. Our recent studies have defined a molecular mechanism for a biological positive-feedback loop that explains how vascular inflammation can be self-sustaining through upregulation of the vessel wall Ang II tone. Ang II produced locally by the inflamed vessel induces the synthesis and…

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000021412.56621.a2

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.
Rajagopalan, S., Kurz, S. D., Münzel, T. F., Tarpey, M. M., Freeman, B. Α., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,467
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,944
Molecular basis of human hypertension: Role of angiotensinogen
Jeunemaı̂tre, X., Soubrier, F., Kotelevtsev, Y. V., Lifton, R. P., Williams, C. S., Charru, A., Hunt, S. C., Hopkins, P. N., Williams, R. R., Lalouel, J.-M., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90275-h · Cited by 1,850
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,828
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Prospective Study of C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Healthy Women
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,575
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Renin-angiotensin system: biochemistry and mechanisms of action.
Peach, M. J. (1977) · Physiological Reviews · doi:10.1152/physrev.1977.57.2.313 · Cited by 1,380
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E–deficient mice
Daugherty, A., Manning, M. W., & Cassis, L. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7818 · Cited by 1,371
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,250
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,137
Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,098
Cellular and molecular mechanisms of endothelial cell dysfunction.
Harrison, D. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119751 · Cited by 1,059
C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction
Ridker, P. M., Glynn, R. J., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.20.2007 · Cited by 1,012
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Plasma Concentration of C-Reactive Protein and Risk of Developing Peripheral Vascular Disease
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.97.5.425 · Cited by 973
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology
Griendling, K. K., Sorescu, D., Lassegue, B. P., & Ushio‐Fukai, M. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Human C-reactive protein: expression, structure, and function
Volanakis, J. E. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 950
The Renin-Angiotensin System
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 949
C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 848
Novel gp91 phox Homologues in Vascular Smooth Muscle Cells: nox1 Mediates Angiotensin II–Induced Superoxide Formation and Redox-Sensitive Signaling Pathways
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly: Results From the Cardiovascular Health Study and the Rural Health Promotion Project
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 799
Tissue Angiotensin and Pathobiology of Vascular Disease
Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 755
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727
Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with Hypertension
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H. W., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 722
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
Warnholtz, A., Nickenig, G., Schulz, E., Macharzina, R. R., Bräsen, J. H., Skatchkov, M. P., Heitzer, T. A., Stasch, J. P., Griendling, K. K., Harrison, D. G., et al. (1999) · Circulation · doi:10.1161/01.cir.99.15.2027 · Cited by 676
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H. G., Rousseau, M. F., Salem, D. N., Kostis, J. B., Benedict, C. R., Bourassa, M. G., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 665
Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques
Schieffer, B., Schieffer, E., Hilfiker‐Kleiner, D., Hilfiker, A., Kovanen, P. T., Kaartinen, M., Nussberger, J., Harringer, W., & Drexler, H. (2000) · Circulation · doi:10.1161/01.cir.101.12.1372 · Cited by 658
Genetic control of blood pressure and the angiotensinogen locus.
Kim, H. S., Krege, J. H., Kluckman, K. D., Hagaman, J. R., Hodgin, J. B., Best, C. F., Jennette, J. C., Coffman, T. M., Maeda, N., & Smithies, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2735 · Cited by 640
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan
Schiffrin, E. L., Park, J. B., Intengan, H. D., & Touyz, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.14.1653 · Cited by 617
Circulating and tissue angiotensin systems.
Campbell, D. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112768 · Cited by 615
Linkage of the Angiotensinogen Gene to Essential Hypertension
Caulfield, M. J., Lavender, P., Farrall, M., Munroe, P. B., Lawson, M., Turner, P., & Clark, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302301 · Cited by 575
Reactive Oxygen Species Mediate the Activation of Akt/Protein Kinase B by Angiotensin II in Vascular Smooth Muscle Cells
Ushio‐Fukai, M., Alexander, R. W., Akers, M., Yin, Q., Fujio, Y., Walsh, K., & Griendling, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22699 · Cited by 558
Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative Stress
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J., & Michel, J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 523
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation
Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505
Endothelial Dysfunction: From Physiology to Therapy
Mombouli, J., & Vanhoutte, P. M. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0844 · Cited by 504
A molecular variant of angiotensinogen associated with preeclampsia
Ward, K., Hata, A., Jeunemaı̂tre, X., Helin, C., Nelson, L., Namikawa, C., Farrington, P., Ogasawara, M., Suzumori, K., TOMODA, S., et al. (1993) · Nature Genetics · doi:10.1038/ng0593-59 · Cited by 494
Angiotensin-Converting Enzyme Inhibition Prevents Arterial Nuclear Factor-κB Activation, Monocyte Chemoattractant Protein-1 Expression, and Macrophage Infiltration in a Rabbit Model of Early Accelerated Atherosclerosis
Hernández-Presa, M. Á., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz‐Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494
p47phox is required for atherosclerotic lesion progression in ApoE–/– mice
Barry-Lane, P. A., Patterson, C., van der Merwe, M., Hu, Z., Holland, S. M., Yeh, E. T. H., & Runge, M. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111927 · Cited by 489
The p300/CBP family: integrating signals with transcription factors and chromatin
Shiama, N. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01048-9 · Cited by 488
Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events
Biasucci, L. M., Liuzzo, G., Fantuzzi, G., Caligiuri, G., Rebuzzi, A. G., Ginnetti, F., Dinarello, C. A., & Maseri, A. (1999) · Circulation · doi:10.1161/01.cir.99.16.2079 · Cited by 484
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 483
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.
Campbell, D. J., & Habener, J. F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112566 · Cited by 481
Amyloid protein SAA is associated with high density lipoprotein from human serum.
Benditt, E. P., & Eriksen, N. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.4025 · Cited by 430
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Angiotensin II Signaling in Vascular Smooth Muscle
Griendling, K. K., Ushio‐Fukai, M., Lassegue, B. P., & Alexander, R. W. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.366 · Cited by 406
Angiotensin II Induces Interleukin-6 Transcription in Vascular Smooth Muscle Cells Through Pleiotropic Activation of Nuclear Factor-κB Transcription Factors
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Self-citation
Angiotensin II Induces Vascular Cell Adhesion Molecule-1 Expression In Rat Vasculature
Tummala, P. E., Chen, X., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 376
Angiotensin II–Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice
Weiss, D., Kools, J. J., & Taylor, W. R. (2001) · Circulation · doi:10.1161/01.cir.103.3.448 · Cited by 370
C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men
Mendall, M. A. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1982 · Cited by 359
Infections, Inflammation, and the Risk of Coronary Heart Disease
Roivainen, M., Viik-Kajander, M., Palosuo, T., Toivanen, P., Leinonen, M., Saikku, P., Tenkanen, L., Manninen, V., Hovi, T., & Mänttäri, M. (2000) · Circulation · doi:10.1161/01.cir.101.3.252 · Cited by 348
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
Rutherford, J. D., Pfeffer, M. A., Moyé, L. A., Davis, B. R., Flaker, G. C., Kowey, P. R., Lamas, G. A., Miller, H., Packer, M., & Rouleau, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.4.1731 · Cited by 330
Stimulation of a Vascular Smooth Muscle Cell NAD(P)H Oxidase by Thrombin
Patterson, C., Ruef, J., Madamanchi, N. R., Barry-Lane, P., Hu, Z., Horaist, C., Ballinger, C. A., Brasier, A. R., Bode, C., & Runge, M. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19814 · Cited by 330
Self-citation
Essential Role of STAT3 in the Control of the Acute-Phase Response as Revealed by Inducible Gene Activation in the Liver
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329
Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects.
Walker, W. G., Whelton, P. K., Saito, H., Russell, R. P., & Hermann, J. (1979) · Hypertension · doi:10.1161/01.hyp.1.3.287 · Cited by 292
Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte‐stimulating factor in the rat
Castell, J. V., Geiger, T. M., Groß, V., Andus, T., WALTER, E., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14383.x · Cited by 290
Role of NAD(P)H Oxidase in Angiotensin II–Induced JAK/STAT Signaling and Cytokine Induction
Schieffer, B., Luchtefeld, M., Braun, S., Hilfiker, A., Hilfiker‐Kleiner, D., & Drexler, H. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1195 · Cited by 275
Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced Hypercholesterolemia
Strawn, W. B., Chappell, M. C., Dean, R. H., Kivlighn, S. D., & Ferrario, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.13.1586 · Cited by 270
Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes
Fukamizu, A., Sugimura, K., Takimoto, E., Sugiyama, F., Seo, M. S., Takahashi, S., Hatae, T., Kajiwara, N., Yagami, K.-I., & Murakami, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50246-0 · Cited by 268
Angiotensin II Induces LOX-1, the Human Endothelial Receptor for Oxidized Low-Density Lipoprotein
Morawietz, H., Rueckschloss, U., Niemann, B., Duerrschmidt, N., Galle, J., Hakim, K., Zerkowski, H., Sawamura, T., & Holtz, J. (1999) · Circulation · doi:10.1161/01.cir.100.9.899 · Cited by 254
Angiotensin II Stimulates Intercellular Adhesion Molecule-1 (ICAM-1) Expression by Human Vascular Endothelial Cells and Increases Soluble ICAM-1 Release In Vivo
Pastore, L., Tessitore, A., Martinotti, S., Toniato, E., Alesse, E., Bravi, M. C., Ferri, C., Desideri, G., Gulino, A., & Santucci, A. (1999) · Circulation · doi:10.1161/01.cir.100.15.1646 · Cited by 249
Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner
Ikeda, U., Ikeda, M., Oohara, T., Oguchi, A., Kamitani, T., Tsuruya, Y., & Kano, S. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.5.h1713 · Cited by 225
Genes coding for RNA polymerase β subunit in bacteria
Lisitsyn, N. A., MONASTYRSKAYA, G. S., & Sverdlov, E. D. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14384.x · Cited by 217
Mechanisms for Inducible Control of Angiotensinogen Gene Transcription
Brasier, A. R., & Li, J. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.465 · Cited by 207
Self-citation
Elevated plasma interleukin-6 levels in patients with acute myocardial infarction
Miyao, Y., Yasue, H., Ogawa, H., Misumi, I., 増田, 武., Sakamoto, T., & Morita, E. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90526-f · Cited by 205
Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis
Prasad, A., Tupas-Habib, T., Schenke, W. H., Mincemoyer, R., Panza, J. A., Waclawin, M. A., Ellahham, S. H., & Quyyumi, A. A. (2000) · Circulation · doi:10.1161/01.cir.101.20.2349 · Cited by 196
Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor
Brasier, A. R., Jamaluddin, M. F., Han, Y., Patterson, C., & Runge, M. S. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007133710837 · Cited by 181
Self-citation
Modulation of C-Reactive Protein-Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 181
Angiotensin II and atherosclerosis
Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 180
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
Navalkar, S., Parthasarathy, S., Santanam, N., & Khan, B. V. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01138-4 · Cited by 171
Angiotensin II and its receptors in the diabetic kidney
Burns, K. D. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.16192 · Cited by 156
Cellular Localization of Angiotensinogen Gene Expression in Brown Adipose Tissue and Mesentery: Quantification of Messenger Ribonucleic Acid Abundance Using Hybridization in Situ*
Campbell, D. J., & Habener, J. F. (1987) · Endocrinology · doi:10.1210/endo-121-5-1616 · Cited by 150
The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice
Hayek, T. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00239-4 · Cited by 146
Molecular Genetics of Human Hypertension: Role of Angiotensinogen
Corvol, P. L., & Jeunemaı̂tre, X. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.5.0312 · Cited by 145
Effects of Losartan on Angiotensin and Bradykinin Peptides and Angiotensin-Converting Enzyme
Campbell, D. J., Kladis, A., & Valentijn, A. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00009 · Cited by 145
Identification of NF-κB-Dependent Gene Networks in Respiratory Syncytial Virus-Infected Cells
Tian, B., Zhang, Y., Luxon, B. A., Garofalo, R. P., Casola, A., Sinha, M., & Brasier, A. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6800-6814.2002 · Cited by 138
Self-citation
Multiple determinants for the high substrate specificity of an angiotensin II-forming chymase from the human heart.
Kinoshita, A., Urata, H., Bumpus, F. M., & Husain, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54981-4 · Cited by 127
Platelet-Derived Interleukin-1 Induces Cytokine Production, but not Proliferation of Human Vascular Smooth Muscle Cells
Loppnow, H., Bil, R., Hirt, S. W., Schönbeck, U., Herzberg, M., Werdan, K., Rietschel, E. T., Brandt, E., & Flad, H. (1998) · Blood · doi:10.1182/blood.v91.1.134 · Cited by 122
Angiotensin II Generation at the Cell Surface of Activated Neutrophils: Novel Cathepsin G-Mediated Catalytic Activity That Is Resistant to Inhibition
Owen, C. A., & Campbell, E. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1436 · Cited by 118
Renin expression by vascular endothelial cells in culture.
Lilly, L. S., Pratt, R. E., Alexander, R. W., Larson, D. M., Ellison, K., Gimbrone, M. A., & Dzau, V. J. (1985) · Circulation Research · doi:10.1161/01.res.57.2.312 · Cited by 116
Angiotensinogen T235 expression is elevated in decidual spiral arteries.
Morgan, T. K., Craven, C., Nelson, L., Lalouel, J.-M., & Ward, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119661 · Cited by 115
Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL
Keidar, S., Heinrich, R., Kaplan, M., Hayek, T., & Aviram, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0901.095547 · Cited by 113
Transcriptional Control Mechanism of Fibrinogen Gene Expression
Fuller, G. M., & Zhang, Z. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03534.x · Cited by 112
An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene.
Ron, D., Brasier, A. R., Wright, K. A., Tate, J. E., & Habener, J. F. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.3.1023 · Cited by 107
Self-citation
Antiatherosclerotic and Antioxidative Effects of Captopril in Apolipoprotein E-Deficient Mice
Hayek, T., Attias, J., Smith, J. D., Breslow, J. L., & Keidar, S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199804000-00011 · Cited by 107
Measurement of Plasma Renin Substrate by Radioimmunoassay of Angiotensin I: Concentration in Syndromes Associated with Steroid Excess
Krakoff, L. R. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-37-1-110 · Cited by 106
Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes
Li, J., & Brasier, A. R. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.3.8833654 · Cited by 104
Self-citation
Angiotensin AT1 Receptor Antagonist Irbesartan Decreases Lesion Size, Chemokine Expression, and Macrophage Accumulation in Apolipoprotein E-Deficient Mice
Dol, F., Martin, G., Staels, B., Marés, A.-M., Cazaubon, C., Nisato, D., Bidouard, J., Janiak, P., Schaeffer, P., & Herbert, J. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200109000-00008 · Cited by 93
Reversing Endothelial Dysfunction With ACE Inhibitors
Rajagopalan, S., & Harrison, D. G. (1996) · Circulation · doi:10.1161/01.cir.94.3.240 · Cited by 86
Angiotensin-Converting Enzyme Inhibition Alters Nitric Oxide and Superoxide Release in Normotensive and Hypertensive Rats
Wiemer, G., Linz, W., Hatrik, S., Schölkens, B. A., & Maliñski, T. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1183 · Cited by 80
AT 1 Receptor Antagonism Reduces Endothelial Dysfunction and Intimal Thickening in Atherosclerotic Rabbits
Heras, N. D. L., Aragoncillo, P., Maeso, R., Vázquez-Pérez, S., Navarro‐Cid, J., deGasparo, M., Mann, J., Ruilope, L. M., Cachofeiro, V., & Lahera, V. (1999) · Hypertension · doi:10.1161/01.hyp.34.4.969 · Cited by 77
Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells
Liang, J.-S., Schreiber, B. M., Salmona, M., Phillip, G., Gonnerman, W. A., de Beer, F. C., & Sipe, J. D. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37293-x · Cited by 75
Angiotensinogen Gene Expression Is Dependent on Signal Transducer and Activator of Transcription 3-Mediated p300/cAMP Response Element Binding Protein-Binding Protein Coactivator Recruitment and Histone Acetyltransferase Activity
Ray, S., Sherman, C. T., Lu, M., & Brasier, A. R. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.824 · Cited by 65
Self-citation
Angiotensin-Converting Enzyme Inhibitors and Insulin Sensitivity: Metabolic Effects in Hypertension, Diabetes, and Heart Failure
Donnelly, R. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199200111-00007 · Cited by 60
Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-angiotensin system.
Sugiyama, F., Haraoka, S., Watanabe, T., Shiota, N., Taniguchi, K., Ueno, Y., Tanimoto, K., Murakami, K., Fukamizu, A., & YAGAMI, K.-I. (1997) · PubMed · Cited by 60
ACE inhibition with perindopril and atherogenesis-induced structural and functional changes in minipig arteries.
Charpiot, P., Rolland, P. H., Friggi, A., Piquet, P., Scalbert, E., Bodard, H., Barlatier, A., Latrille, V., Tranier, P., & Mercier, C. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.8.1125 · Cited by 58
Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease
Halkin, A., & Keren, G. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01001-4 · Cited by 54
Ramipril Prevents Endothelial Dysfunction Induced by Oxidized Low-Density Lipoproteins
Berkenboom, G. M., Langer, I., Carpentier, Y., Grosfils, K., & Fontaine, J. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.371 · Cited by 53
A comparison of the substrate specificities of cathepsin D and pseudorenin.
Dorer, F. E., Lentz, K. E., Kahn, J. R., Levine, M. A., & Skeggs, L. T. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40814-3 · Cited by 52
Role of Signal Transducers and Activators of Transcription 1 and -3 in Inducible Regulation of the Human Angiotensinogen Gene by Interleukin-6
Sherman, C. T., & Brasier, A. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.3.441 · Cited by 49
Self-citation
Proteolytic degradation of low density lipoproteins by arterial smooth muscle cells
Leake, D. S., & Peters, T. J. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90033-3 · Cited by 40
Regulation of the angiotensin AT1 receptor expression by hypercholesterolemia.
Nickenig, G., & Böhm, M. (1997) · PubMed · Cited by 37
Chemistry of a human monocyte-derived cell line (U937): identification of the angiotensin I-converting activity as leukocyte cathepsin G
Snyder, R., Kaempfer, C. E., & Wintroub, B. (1985) · Blood · doi:10.1182/blood.v65.1.176.176 · Cited by 33
Angiotensinogen is an acute-phase protein in man
Nielsen, A. H., & Knudsen, F. (1987) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365518709168886 · Cited by 28
Transcription Factors NF‐IL6 and APRF Involved in gp130‐mediated Signaling Pathway a
Akira, S., Nishio, Y., Tanaka, T., Inoue, M., Matsusaka, T., Wang, X.-J., Wei, S., Yoshida, N., & Kishimoto, T. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32310.x · Cited by 27
Effects of Quinapril and Losartan on Insulin Sensitivity in Genetic Hypertensive Rats with Different Metabolic Abnormalities
Nakagawa, H., Daihara, M., Tamakawa, H., Nozue, T., & Kawahara, K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199907000-00005 · Cited by 24
Acute phase responses of plasma angiotensinogen and T-kininogen in rats
Okamoto, H., Hatta, A., Itoh, N., Ohashi, Y., Arakawa, K., & Nakanishi, S. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90225-5 · Cited by 23
Attenuation of Tissue P-Selectin and MCP-1 Expression and Intimal Proliferation by AT1 Receptor Blockade in Hyperlipidemic Rabbits
Chen, H. J., Li, D. Y., Saldeen, T. G. P., Phillips, M. I., & Mehta, J. L. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4590 · Cited by 20
The intracellular distribution of cathepsins and other acid hydrolases in mouse peritoneal macrophages.
Wiener, E., & Curelaru, Z. (1975) · PubMed · Cited by 11

Research works printed but not linked: 63

10.1161/circ.104.3.365 · DOI
2000, Pharmacol Rev, 52, 11
10.1161/hyp.37.4.1047 · DOI
10.1161/circ.90.4.7923656 · DOI
1993, Arterioscler Thromb Vasc Biol, 12, 1125
1992, J Cardiovasc Pharmacol, 20, 38
10.1161/hyp.30.3.371 · DOI
10.1161/hyp.30.5.1183 · DOI
10.1161/circ.94.3.240 · DOI
10.1161/circ.101.14.1653 · DOI
10.1161/circ.101.20.2349 · DOI
10.1161/circ.101.13.1586 · DOI
2001, J Cardiovasc Pharmacol, 28, 395
10.1161/hyp.34.4.969 · DOI
1997, Lab Invest, 76, 835
10.1161/circ.103.3.448 · DOI
2001, J Clin Invest, 105, 1605
10.1161/res.74.6.8187280 · DOI
10.1161/circ.99.15.2027 · DOI
2001, Mol Cell Biochem, 212, 155
10.1161/hyp.29.1.366 · DOI
10.1161/res.87.12.1195 · DOI
10.1161/res.86.5.494 · DOI
10.1161/atvb.20.10.2175 · DOI
10.1161/res.88.9.888 · DOI
10.1161/atvb.21.9.1464 · DOI
10.1161/circ.100.9.899 · DOI
10.1161/atvb.20.3.645 · DOI
10.1161/circ.100.15.1646 · DOI
10.1161/circ.100.11.1223 · DOI
10.1161/circ.95.6.1532 · DOI
10.1161/res.84.6.695 · DOI
10.1161/atvb.19.7.1623 · DOI
1998, Nature, 294, 894
1991, Am J Physiol, 260, H1713
1996, Mol Endocrinol, 10, 252
10.1161/circ.99.16.2079 · DOI
10.1161/circ.101.15.1767 · DOI
2001, N Engl J Med, 342, 836
10.1161/circ.98.8.731 · DOI
10.1161/circ.97.5.425 · DOI
10.1161/atvb.17.6.1121 · DOI
10.1161/circ.99.2.237 · DOI
10.1161/circ.101.3.252 · DOI
2001, BMJ, 321, 199
2001, Eur Heart J, 21, 1584
10.1161/circ.97.20.2007 · DOI
10.1210/mend.16.4.0811 · DOI
1995, Ann N Y Acad Sci, 762, 12
10.1210/mend.15.3.0609 · DOI
Brasier AR Recinos AI Eledrisi MS. Mechanisms for vascular inflammation as a cardiovascular risk factor.In: Runge M Patterson C eds. Principles of Molecular Cardiology. Totowa NJ: Humana Press; 2002.
1998, Endocrinology, 121, 1616
10.1161/circ.103.9.1194 · DOI
10.1161/circ.103.21.2531 · DOI
10.1161/circ.102.18.2165 · DOI
1997, Endocr Rev, 18, 662
1998, Nat Genet, 4, 59
10.3109/00365518709168886 · DOI
10.1161/res.57.2.3893789 · DOI
1975, J Reticuloendothel Soc, 17, 319
10.1161/circ.94.11.2756 · DOI
10.1161/circ.101.12.1372 · DOI
1997, Eur J Med Res, 2, 285

Sorted by citations

IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
“The AngII–AT1R axis activates the NF-κ B pathway through various growth factors and pro-inflammatory cytokines (347, 348).”
Background
Inflammatory cytokines in vascular dysfunction and vascular disease
Sprague, A. H., & Khalil, R. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.029 · Cited by 1,381
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R. G., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,135
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,013
Inflammation in Heart Failure
Murphy, S., Kakkar, R. K., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 791

See all 586

Authors: Brasier, A. R., Recinos, A., & Eledrisi, M. S.
Affiliations: The University of Texas Medical Branch at Galveston (US)
From the Departments of Medicine (A.R.B., A.R., M.S.E.) and Human Biological Chemistry and Genetics (A.R.B.) and the Sealy Center for Molecular Sciences (A.R.B.), The University of Texas Medical Branch, Galveston.
ORCID: Brasier, Allan R.
Eledrisi, Mohsen S.
Venue: Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2002-08
Volume: 22
Issue: 8
Pages: 1257-1266
ISSN: 1079-5642 (ISSN-L)
1524-4636
DOI: 10.1161/01.atv.0000021412.56621.a2
OpenAlex: W2154360613
Cited by: 586
References: 126
Citations by year: 2026: 4 · 2025: 17 · 2024: 12 · 2023: 16 · 2022: 9 · 2021: 20 · 2020: 21 · 2019: 12 · 2018: 16 · 2017: 22 · 2016: 24 · 2015: 22 · 2014: 25 · 2013: 22 · 2012: 29
FWCI: 5.16
Type: journal article
Language: en
Open access: closed
Locations: Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (55630)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: vascular inflammation, renin-angiotensin system, angiotensin II, atherosclerosis, interleukin-6, nuclear factor-kappaB, JAK/STAT3 signaling, angiotensinogen, oxidized lipids, endothelial dysfunction, monocyte recruitment, reactive oxygen species, ischemic heart disease
MeSH terms: Acute-Phase Proteins, Angiotensin II, Animals, Arteriosclerosis, Endothelium, Vascular, Humans, Inflammation, Cholesterol, LDL, Liver, Macrophages, Monocytes, Oxidation-Reduction, Renin-Angiotensin System, Signal Transduction, Interleukin-6, Reactive Oxygen Species, Feedback, Physiological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Vascular Inflammation and the Renin-Angiotensin System

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks